Engineering tumors with 3D scaffolds

Microenvironmental conditions control tumorigenesis and biomimetic culture systems that allow for in vitro and in vivo tumor modeling may greatly aid studies of cancer cells' dependency on these conditions. We engineered three-dimensional (3D) human tumor models using carcinoma cells in polymeric scaffolds that recreated microenvironmental characteristics representative of tumors in vivo. Strikingly, the angiogenic characteristics of tumor cells were dramatically altered upon 3D culture within this system, and corresponded much more closely to tumors formed in vivo. Cells in this model were also less sensitive to chemotherapy and yielded tumors with enhanced malignant potential. We assessed the broad relevance of these findings with 3D culture of other tumor cell lines in this same model, comparison with standard 3D Matrigel culture and in vivo experiments. This new biomimetic model may provide a broadly applicable 3D culture system to study the effect of microenvironmental conditions on tumor malignancy in vitro and in vivo.

[1]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[2]  M. Poupon,et al.  Distinctive alterations of invasiveness, drug resistance and cell–cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant , 2004, Clinical & Experimental Metastasis.

[3]  Nastaran Zahir,et al.  Autocrine laminin-5 ligates α6β4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors , 2003, The Journal of cell biology.

[4]  Giulio Gabbiani,et al.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.

[5]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[6]  Jayanta Debnath,et al.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.

[7]  Hai Lu,et al.  Squamous Cell Carcinoma Cell Aggregates Escape Suspension-induced, p53-mediated Anoikis , 2004, Journal of Biological Chemistry.

[8]  Jayanta Debnath,et al.  Modelling glandular epithelial cancers in three-dimensional cultures , 2005, Nature Reviews Cancer.

[9]  Genee Y. Lee,et al.  Three-dimensional culture models of normal and malignant breast epithelial cells , 2007, Nature Methods.

[10]  B. Dave,et al.  Autocrine Role of Interleukin-8 in Induction of Endothelial Cell Proliferation, Survival, Migration and MMP-2 Production and Angiogenesis , 2005, Angiogenesis.

[11]  F. Watt,et al.  New roles for integrins in squamous-cell carcinoma , 2006, Nature Reviews Cancer.

[12]  Eben Alsberg,et al.  Engineering growing tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  N. Fusenig,et al.  Friends or foes — bipolar effects of the tumour stroma in cancer , 2004, Nature Reviews Cancer.

[14]  T. Carey,et al.  Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion , 1996, The Journal of cell biology.

[15]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[16]  M. Adam,et al.  Oxygen tension measurements of tumors growing in mice. , 1999, International journal of radiation oncology, biology, physics.

[17]  G. Christofori.  New signals from the invasive front , 2006, Nature.

[18]  Hai Lu,et al.  Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. , 2004, The Journal of biological chemistry.

[19]  Qiang Xu,et al.  Interaction between integrin alpha(5) and fibronectin is required for metastasis of B16F10 melanoma cells. , 2005, Biochemical and biophysical research communications.

[20]  J. Folkman,et al.  Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.

[21]  Claudia Fischbach,et al.  Combination treatment significantly enhances the efficacy of antitumor therapy by preferentially targeting angiogenesis , 2005, Laboratory Investigation.

[22]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[23]  K. Xie,et al.  Interleukin-8 and human cancer biology. , 2001, Cytokine & growth factor reviews.

[24]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[25]  Manish Gala,et al.  Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells , 2005, Nature Medicine.

[26]  Barry L Ziober,et al.  Suppression of laminin-5 expression leads to increased motility, tumorigenicity, and invasion. , 2005, Experimental cell research.

[27]  Napoleone Ferrara,et al.  Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. , 2005, Biochemical and biophysical research communications.

[28]  D J Mooney,et al.  Open pore biodegradable matrices formed with gas foaming. , 1998, Journal of biomedical materials research.

[29]  H. Gabbert,et al.  Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. , 1986, Cancer research.

[30]  H. Spring,et al.  Tumor cell invasiveness correlates with changes in integrin expression and localization , 2005, Oncogene.

[31]  P. Corry,et al.  Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway , 1999, Molecular and Cellular Biochemistry.